Bacil Pharma Ltd.

Financial

	Bacil Pharma	Phaarmasia	Ishita Drugs & Inds.
Operational Metrics
Financials
5 yr Average ROE	-73.86 %	-4.64 %	8.34 %
5yr average Equity Multiplier	1.72	2.31	1.24
5yr Average Asset Turnover Ratio	0.0	0.88	1.36
5yr Avg Net Profit Margin	0.0	-2.3 %	5.01 %
Price to Book	12.43	2.01	2.14
P/E	59.54	0.0	25.7
5yr Avg Cash Conversion Cycle	0.0	-185.24 Days	40.65 Days
Inventory Days	0.0	80.36 Days	24.87 Days
Days Receivable	0.0	92.79 Days	30.03 Days
Days Payable	23.71 Days	365.75 Days	48.29 Days
5yr Average Interest Coverage Ratio	-950.16	-67.17	25.37
5yr Avg ROCE	-81.01 %	-3.88 %	11.35 %
5yr Avg Operating Profit Margin	0.0	-3.07 %	6.35 %
5 yr average Debt to Equity	0.08	0.0	0.03
5yr CAGR Net Profit	-28.45 %	n/a	6.4 %
5yr Average Return on Assets	-72.13 %	-2.07 %	6.76 %
Shareholdings
Promoter Holding	10.6 %	73.51 %	49.85 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-32.07 %	0.0	1.48 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0